Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophrenia

[1]  D. Larabi,et al.  Brain areas associated with clinical and cognitive insight in psychotic disorders: A systematic review and meta-analysis , 2020, Neuroscience & Biobehavioral Reviews.

[2]  Y. Iwata,et al.  Insight and medication adherence in schizophrenia: An analysis of the CATIE trial , 2020, Neuropharmacology.

[3]  G. Remington,et al.  Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity. , 2020, Journal of psychiatric research.

[4]  G. Remington,et al.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  B. Pollock,et al.  Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia , 2019, European Psychiatry.

[6]  Christine L. Tardif,et al.  MR‐based age‐related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan , 2019, Human brain mapping.

[7]  Gabriel A. Devenyi,et al.  Identifying schizophrenia subgroups using clustering and supervised learning , 2019, Schizophrenia Research.

[8]  M. Chakravarty,et al.  Evidence for Network-Based Cortical Thickness Reductions in Schizophrenia. , 2019, The American journal of psychiatry.

[9]  B. Pollock,et al.  Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrity , 2019, npj Schizophrenia.

[10]  G. Remington,et al.  Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study , 2019, Biological Psychiatry.

[11]  M. Chakravarty,et al.  Clarifying associations between cortical thickness, subcortical structures, and a comprehensive assessment of clinical insight in enduring schizophrenia , 2019, Schizophrenia Research.

[12]  L. Qiu,et al.  A preliminary study , 2018, Medicine.

[13]  D Louis Collins,et al.  Warping an atlas derived from serial histology to 5 high-resolution MRIs , 2018, Scientific Data.

[14]  B. Pollock,et al.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia , 2018, International journal of geriatric psychiatry.

[15]  J. Vohs,et al.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments , 2018, World psychiatry : official journal of the World Psychiatric Association.

[16]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[17]  M. Zimmerman,et al.  Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice? , 2018, Journal of affective disorders.

[18]  M. Lepage,et al.  Longitudinal trajectory of clinical insight and covariation with cortical thickness in first-episode psychosis. , 2017, Journal of psychiatric research.

[19]  H. Möller,et al.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. , 2017, The American journal of psychiatry.

[20]  Chunshui Yu,et al.  Selective functional disconnection of the orbitofrontal subregions in schizophrenia , 2017, Psychological Medicine.

[21]  T. Lincoln,et al.  The impact of negative treatment experiences on persistent refusal of antipsychotics. , 2016, Comprehensive psychiatry.

[22]  D. Ffytche,et al.  Voxel-based magnetic resonance imaging investigation of poor and preserved clinical insight in people with schizophrenia , 2016, World journal of psychiatry.

[23]  G. Fond,et al.  Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset. , 2016, The Journal of clinical psychiatry.

[24]  M. Chakravarty,et al.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity , 2016, Neuropsychopharmacology.

[25]  Allison Vorderstrasse,et al.  Neurobiological Basis of Insight in Schizophrenia: A Systematic Review , 2016, Nursing research.

[26]  S. Bray,et al.  Cognitive insight is associated with cortical thickness in first-episode psychosis , 2016, Schizophrenia Research.

[27]  Jan Derrfuss,et al.  Different Roles of Direct and Indirect Frontoparietal Pathways for Individual Working Memory Capacity , 2016, The Journal of Neuroscience.

[28]  A. Graff-Guerrero,et al.  Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction. , 2016, Schizophrenia bulletin.

[29]  M. Chakravarty,et al.  Cortical thickness and low insight into symptoms in enduring schizophrenia , 2016, Schizophrenia Research.

[30]  J. Turner,et al.  Abnormal asymmetries in subcortical brain volume in schizophrenia , 2016, Molecular Psychiatry.

[31]  M. Chakravarty,et al.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment. , 2015, Journal of Alzheimer's disease : JAD.

[32]  I. Melle,et al.  Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium , 2016, Molecular Psychiatry.

[33]  Branislava Ćurčić-Blake,et al.  Insight and psychosis: Functional and anatomical brain connectivity and self‐reflection in Schizophrenia , 2015, Human brain mapping.

[34]  R. Kahn,et al.  Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies , 2015, European Neuropsychopharmacology.

[35]  M. Keshavan,et al.  Neurobiology of insight deficits in schizophrenia: An fMRI study , 2015, Schizophrenia Research.

[36]  G. Barker,et al.  Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment , 2015, Neuropsychopharmacology.

[37]  V. Anderson,et al.  Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia , 2015, The international journal of neuropsychopharmacology.

[38]  B. Pollock,et al.  Illness denial in schizophrenia spectrum disorders , 2015, Human brain mapping.

[39]  B. Biswal.  Resting-State Functional Connectivity , 2015 .

[40]  B. Pollock,et al.  The VAGUS insight into psychosis scale – Self-report and clinician-rated versions , 2014, Psychiatry Research.

[41]  B. Pollock,et al.  Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: Resting state functional connectivity , 2014, Schizophrenia Research.

[42]  T. Rajji,et al.  The effects of aging on insight into illness in schizophrenia: a review , 2014, International journal of geriatric psychiatry.

[43]  M. Mallar Chakravarty,et al.  Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates , 2014, NeuroImage.

[44]  R. Murray,et al.  Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function , 2014, Biological Psychiatry.

[45]  B. Pollock,et al.  Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: An analysis of the CATIE data , 2013, Schizophrenia Research.

[46]  D. Collins,et al.  Performing label‐fusion‐based segmentation using multiple automatically generated templates , 2013, Human brain mapping.

[47]  B. Pollock,et al.  Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia , 2013, Human brain mapping.

[48]  Willem A. Nolen,et al.  Insight in Schizophrenia: Involvement of Self-Reflection Networks? , 2012, Schizophrenia bulletin.

[49]  R. Murray,et al.  Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. , 2012, The American journal of psychiatry.

[50]  M. Tampakeras,et al.  DISC1 and Striatal Volume: A Potential Risk Phenotype For mental Illness , 2012, Front. Psychiatry.

[51]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[52]  D. Louis Collins,et al.  BEaST: Brain extraction based on nonlocal segmentation technique , 2012, NeuroImage.

[53]  G. Barker,et al.  Association of grey matter volume deviation with insight impairment in first-episode affective and non-affective psychosis , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[54]  B. Ardekani,et al.  White matter integrity and lack of insight in schizophrenia and schizoaffective disorder , 2011, Schizophrenia Research.

[55]  J. Castro-Fornieles,et al.  Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. , 2011, Schizophrenia bulletin.

[56]  L. de Haan,et al.  Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? , 2010, Journal of psychiatric research.

[57]  Josep Maria Haro,et al.  Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia , 2010, Psychiatry Research.

[58]  N. Gogtay,et al.  Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia , 2010, Schizophrenia Research.

[59]  Alan C. Evans,et al.  Depth potential function for folding pattern representation, registration and analysis , 2009, Medical Image Anal..

[60]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[61]  G. L. Huber,et al.  A 2-Year Longitudinal Study , 2008 .

[62]  R. Woods,et al.  Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. , 2007, Cerebral cortex.

[63]  Steven Robbins,et al.  An unbiased iterative group registration template for cortical surface analysis , 2007, NeuroImage.

[64]  P. Buckley,et al.  Lack of Insight in Schizophrenia , 2007, CNS drugs.

[65]  Alan N. Francis,et al.  Prefrontal cortex and insight in schizophrenia: A volumetric MRI study , 2007, Schizophrenia Research.

[66]  M. Keshavan,et al.  Neurobiological underpinnings of insight deficits in schizophrenia , 2007, International review of psychiatry.

[67]  W. Rief,et al.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. , 2006, Schizophrenia bulletin.

[68]  M. Keshavan,et al.  Prefrontal subregions and dimensions of insight in first-episode schizophrenia — A pilot study , 2006, Psychiatry Research: Neuroimaging.

[69]  D. Collins,et al.  The creation of a brain atlas for image guided neurosurgery using serial histological data , 2003, NeuroImage.

[70]  Alan C. Evans,et al.  Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification , 2005, NeuroImage.

[71]  Dottie M. Clower,et al.  Basal ganglia and cerebellar inputs to 'AIP'. , 2005, Cerebral cortex.

[72]  Alan C. Evans,et al.  Cortical thickness analysis examined through power analysis and a population simulation , 2005, NeuroImage.

[73]  Jason Lerch,et al.  Native-Space Cortical Thickness Measurement And The Absence of Correlation to Cerebral Volume , 2005 .

[74]  Nancy C. Andreasen,et al.  Temporal pole morphology and psychopathology in males with schizophrenia , 2004, Psychiatry Research: Neuroimaging.

[75]  Alan C. Evans,et al.  Fast and robust parameter estimation for statistical partial volume models in brain MRI , 2004, NeuroImage.

[76]  Matcheri S Keshavan,et al.  Insight and prefrontal cortex in first-episode Schizophrenia , 2004, NeuroImage.

[77]  K. Dobson,et al.  Insight in schizophrenia: a meta-analysis , 2003, Schizophrenia Research.

[78]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[79]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[80]  B. Svarstad,et al.  Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. , 2001, Psychiatric services.

[81]  R. L. Green,et al.  Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[82]  Alan C. Evans,et al.  Automated 3-D Extraction of Inner and Outer Surfaces of Cerebral Cortex from MRI , 2000, NeuroImage.

[83]  H. Möller,et al.  Rating depressed patients: observer- vs self-assessment. , 2000, European psychiatry : the journal of the Association of European Psychiatrists.

[84]  Alan C. Evans,et al.  Automatic Quantification of MS Lesions in 3D MRI Brain Data Sets: Validation of INSECT , 1998, MICCAI.

[85]  Thomas Grisso,et al.  Mental Illness and Competence to Consent to Treatment , 1995 .

[86]  N C Andreasen,et al.  Awareness of illness in schizophrenia and schizoaffective and mood disorders. , 1994, Archives of general psychiatry.

[87]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[88]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[89]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[90]  Robert C. Wolpert,et al.  A Review of the , 1985 .